Navigation Links
Central and Eastern European Healthcare Markets Hold Strong Potential for Growth Despite the Economic Slowdown, Says Frost & Sullivan

LONDON, Nov. 10 /PRNewswire/ -- Despite the global economic decline, Central and Eastern European (CEE) countries such as Poland, the Czech Republic, Slovakia, Hungary, Bulgaria and Romania still represent an attractive healthcare market. Both the pharmaceutical as well as medical devices segments have not developed to their full potential, with healthcare expenditures expected to rise further. The increasing importance of this market is attracting multinational corporations (MNCs) for developing proprietary or acquiring local production sites. Merger with or an acquisition of a local market participant is considered as the most efficient way to access the local market and to further expand into the CEE markets.


New analysis from Frost & Sullivan (, Overview of Pharmaceutical and Medical Devices Industry in Central and Eastern Europe, finds that the pharmaceutical and medical devices market will grow on average at 6.9 per cent and 7.4 per cent respectively from 2009 to 2012. Bulgaria and Romania will be the fastest-growing markets, while the Czech and Hungarian markets will experience below-average growth.

If you are interested in more information about this study, then send an e-mail to Katja Feick, Corporate Communications, at, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country.

"On one hand, the Western European markets are saturated with marginal scope for growth," says Frost & Sullivan Research Analyst Vitaliy Lehkyy. "On the other hand, CEE countries still boast of an unmet demand for pharmaceuticals and medical devices, driven by the rising purchasing power of the population."

CEE pharmaceutical and medical devices markets are on average 1.5 to five times smaller in value terms per capita than the Western European ones. The improving economic position of countries in the region is resulting in a better quality of life, higher life expectancy and a consequent demand for efficient healthcare services by the ageing population.

However, the markets will be restrained by incoherent reforms of the healthcare system and volatile regulatory requirements imposed on market participants.

"For instance, compulsory fees for drug prescription in the Czech Republic and Hungary, a new pharmaceutical pricing scheme in Slovakia, and mandatory labelling of all medicaments in Cyrillic alphabet in Bulgaria, will adversely affect the market in the short-term," explains Lehkyy. "These measures imply an additional cost pressure either on consumers or drug-manufacturers and will have an adverse effect on the development of pharmaceutical markets in these countries."

Therefore, timely and effective response from government authorities will be crucial to the favourable development of the healthcare market in CEE.

Overview of Pharmaceutical and Medical Devices Industry in Central and Eastern Europe is part of the Pharmaceuticals & Biotechnology Growth Partnership Services programme, which also includes research in the following markets: Global Active Pharmaceutical Ingredients Market Outlook, European Biomarker Analysis Market, and Emerging Therapeutic Segments in the European Biopharmaceutical Market. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 35 offices on six continents. To join our Growth Partnership, please visit

Overview of Pharmaceutical and Medical Devices Industry in Central and Eastern Europe


    Katja Feick
    Corporate Communications - Europe
    P: +49 (0) 69 7703343

SOURCE Frost & Sullivan

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Hope for Emphysema Sufferers: Clinical Trial That May Help Patients Breathe Easier Begins at Central DuPage Hospital
2. Global Health Research Foundation Awarded $25,000 Grant From Westly Foundation to Study Asthma in Californias Central Valley
3. 10-State Project to Study Methods to Reduce Central Line-Associated Bloodstream Infections in Hospital ICUs
4. BARC Central Laboratory Joins Alzheimers Association Research Roundtable
5. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
6. EPSScentral Responds to Pandemic Alert
7. Mobile Dog Heart Health Tour Stopping in Central Park to Provide Free Heart Examinations
8. St. Davids South Austin Hospital Leading the Central Texas Region in Laser-Assisted Lead-Extraction Procedures
9. Private Investment Firm Czura Thornton Today Introduces Clearstone Central Laboratories as the Newest Member of the Czura Thornton Life Science Group
10. PharmAthene to Webcast its Third Quarter Conference Call on November 13, 2007 at 4:30 P.M. Eastern Time
11. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
Post Your Comments:
(Date:11/26/2015)... , Nov. 26, 2015 Research and ... of the "2016 Future Horizons and Growth ... Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, ... --> --> ... of the Italian therapeutic drug monitoring market, including ...
(Date:11/26/2015)... 2015 ... the  "2016 Future Horizons and Growth ... Marker Testing Market: Supplier Shares, Competitive ... offering.  --> ) ... "2016 Future Horizons and Growth Strategies ...
(Date:11/25/2015)... SYDNEY , Nov. 26, 2015  The total global ... nearly 7% over 2015-2016. Latin America ... Asia , (excluding Japan ), is ... continues to face increased healthcare expenditure. In 2013-2014, ... expenditure declined from 43.5% in 2008-2009 to 41.2% in 2013-2014. ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare ... participated in the 61st annual Employee Benefits Conference. The Employee Benefits Conference was ... November 8th through Wednesday, November 11th, 2015. The conference was held at the ...
(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and ... an application server to improve system efficiency and reliability. , The new Q-Suite 6 ... these standards, the system avoids locking itself into a specific piece of software for ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... the perfect dish and pleasing the palates of attendees is of the utmost ... dish to a seasonal get-together, give these recipes a try this holiday season. ...
(Date:11/25/2015)... ... November 25, 2015 , ... TyloHelo ... parts and accessories. , Sauna accessories help improve the bather experience in the ... From basic styles for the purist looking for simplicity in design to accessories ...
(Date:11/25/2015)... Rouge, LA (PRWEB) , ... November 25, 2015 , ... ... in the United States District Court of Connecticut on behalf of a home health ... behalf of all current or former home health care workers employed by Humana, Inc., ...
Breaking Medicine News(10 mins):